Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News NeonMind Biosciences C.NEON

Alternate Symbol(s):  NMDBF

NeonMind Biosciences Inc is engaged in preclinical research to develop potential clinical treatments and wellness products to address obesity and weight management conditions and to promote health and wellness. The company operates three divisions: a pharmaceutical division engaged in drug development of psychedelic compounds with two lead psilocybin-based drug candidates targeting obesity; a medical services division focused on launching specialty mental health clinics that integrate psychedelic therapeutics into traditional psychotherapy settings; and a consumer products division that currently sells mushroom-infused products to promote health and wellness.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (CSE:NEON)

Fundamentals Snapshot (CSE:NEON)

Bullboard Posts (CSE:NEON)

𓋼🤑𓋼 Mushroom News ~ Roadmap for 2022 & Early 2023

Lobe is preparing a pre-IND meeting request with the US Food and Drug Administration (FDA) to confirm its regulatory strategy and Phase I...
AllForTheMoney - June 16, 2022

NeonMind To Improve Patient Care

Engages Thrive Health, a Leading Digital Patient Care Platform to Streamline Care Programs and Data Collection OAKVILLE, ON...
Betteryear2 - April 21, 2022

i did own this one sold last year

still looks like a bad investment
armordeck - January 17, 2022

Addition of Mental Health Expert to Specialty Clinics Board

https://neonmindbiosciences.com/neonmind-appoints-ketamine-and-neurostimulation-expert-dr-roumen-milev-md-phd-to-specialty-clinic...
venturecap4768 - September 16, 2021

Rob Tessarolo on Midas Letter RAW

See link here
sr71loki - May 14, 2021

New Telegram Group Chat! Join Now!

https://t.me/NeonmindBiosciences
equitystandard - May 6, 2021